Custom High-Loading EGCG Nanoparticles Development Service for Enhanced Combination Antitumor Therapy

0
6

Natural products have great potential in biomedical research, drug development and clinical applications as they can be used medicinal sources to treat cancer, bacterial and fungal infections, inflammation and other diseases. These compounds in particular exhibit excellent biocompatibility, broad-spectrum biological activity and highly targeted effects, making them potent anti-cancer chemopreventive and chemotherapeutic agents with minimal side effects. Furthermore, these abundant and diverse natural sources can help to reduce the cost of cancer treatment.

EGCG is a natural phenolic compound found in foods and beverages (particularly tea) that exhibits a wide range of biological activities, including antioxidant, antibacterial, anti-obesity, anti-inflammatory and anticancer properties. The formation of EGCG self-assembled nanoparticles (ENPs) during the oxidation process is driven by intermolecular interactions, which maintain the stability of the nanoparticles. EGCG-based nanoparticles are an excellent carrier platform for antitumour drug delivery. To support researchers' work, CD Bioparticles now offers a high-loading EGCG-based nanoparticle platform designed specifically for combined antitumour therapy and efficient drug delivery.

CD Bioparticles offers custom, high-loading EGCG nanoparticle services to leverage advanced nanomedicine delivery technologies to achieve high loading, controlled release and targeted delivery, thereby maximizing the therapeutic potential of EGCG. The platform achieves loading rates of 30–50% (compared to 5–10% for traditional carriers), thereby increasing the effective dose while reducing the required carrier amount.

Additionally, the platform offers broad drug compatibility and is capable of simultaneously loading both hydrophilic and hydrophobic drugs, providing an efficient platform for multi-drug combination therapy. CD Bioparticles supports anti-tumour combination therapy regimens to achieve drug synergy and improve treatment outcomes. With a particle size range of 100–200 nm, CD Bioparticles' nanoparticles enhance tumour permeability and cellular uptake.

CD Bioparticles' comprehensive services include nanoparticle preparation customization, drug loading and capacity optimization, precise particle size and morphology characterization, stability and release performance evaluation, biocompatibility and efficacy assessment, and scalable production. These services can support researchers in various applications, such as in vitro drug screening and delivery mechanism studies, antitumour combination drug delivery, and targeted drug delivery and nanomedicine development.

Researchers and pharmaceutical developers working in oncology, targeted nanomedicine and sustained-release systems R&D who would like to learn more about CD Bioparticles' High-Loading-Capacity EGCG Nanoparticle Development services, or who would like to discuss custom project requirements and explore available development solutions, please visit https://www.cd-bioparticles.net/services/custom-high-loading-egcg-nanoparticles-development-service.html.

About CD Bioparticles

CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.

Поиск
Категории
Больше
Другое
Statcom For Renewable Energy Grid Stabilization: Enhancing Power Quality in the Energy Transition
The rapid expansion of renewable energy sources, such as wind and solar, presents significant...
От Rushi Sanap 2026-06-29 08:53:44 0 1Кб
Health
Mobile Digital X-Ray System Market – Supporting Bedside Imaging and Emergency Diagnostics
The Mobile Digital X-Ray System Market is closely connected to the growing need for flexible...
От Shakira Mrfr 2026-11-13 08:45:17 0 67
Networking
Global Bioterrorism Agent Market Size, Trends and Industry Analysis
According to the latest report published by Data Bridge Market Research, the  Bioterrorism...
От Shivam Kumar 2026-11-09 07:48:02 0 163
Health
Neuraminidase Inhibitors Market Report 2026: Industry Size, Emerging Trends, and Business Opportunities
"According to the latest report published by Data Bridge Market...
От Akanksha Didmuthe 2026-06-30 15:57:11 0 832
Другое
PW Consulting: Hair Styling Tools Market at USD 38,461.7M in 2025; 5.19% CAGR Forecast Through 2032
Hair Styling Tools Market — Strategic Preview for 2026 PW Consulting’s new industry...
От Ryan Lee 2026-08-28 13:36:42 0 203